93 related articles for article (PubMed ID: 14632176)
1. The great escape: another way for melanoma to leave physiological control?
Smalley KS; Herlyn M
J Invest Dermatol; 2003 Oct; 121(4):xi-xii. PubMed ID: 14632176
[No Abstract] [Full Text] [Related]
2. Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.
Smalley KS; Herlyn M
J Invest Dermatol; 2004 Oct; 123(4):xvi-xvii. PubMed ID: 15373800
[No Abstract] [Full Text] [Related]
3. Prognostic models for melanoma.
Elder DE
J Cutan Pathol; 2010 Apr; 37 Suppl 1():68-75. PubMed ID: 20482678
[No Abstract] [Full Text] [Related]
4. Growth regulation in normal and malignant melanocytes.
Halaban R
Recent Results Cancer Res; 1993; 128():133-50. PubMed ID: 8356315
[No Abstract] [Full Text] [Related]
5. Melanoma: do we need a hatchet or a scalpel?
Shackleton MJ; Quintana E; Fullen DR; Sabel MS; Johnson TM
Arch Dermatol; 2009 Mar; 145(3):307-8. PubMed ID: 19289763
[No Abstract] [Full Text] [Related]
6. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
Kurdoglu M; Güllü IH; Akalin I
Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
[TBL] [Abstract][Full Text] [Related]
7. Objective melanoma progression.
Rubegni P; Burroni M; Nami N; Cevenini G; Bono R; Sbano P; Fimiani M
Skin Res Technol; 2011 Feb; 17(1):69-74. PubMed ID: 20923468
[TBL] [Abstract][Full Text] [Related]
8. Autocrine growth stimulation as a potential source of asymmetry in melanocytic skin tumors.
Smolle J; Hofmann-Wellenhof R
Am J Dermatopathol; 1998 Aug; 20(4):352-6. PubMed ID: 9700372
[TBL] [Abstract][Full Text] [Related]
9. [Follow-up of malignant melanoma].
Truchetet F; Chartier C; Heid E
Ann Dermatol Venereol; 1989; 116(5):437-40. PubMed ID: 2675740
[No Abstract] [Full Text] [Related]
10. [Malignant melanoma. Pathological anatomy].
Wechsler J; Belaich S
Rev Prat; 1993 Sep; 43(13):1743-6. PubMed ID: 8303202
[No Abstract] [Full Text] [Related]
11. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
Houben R; Ortmann S; Drasche A; Troppmair J; Herold MJ; Becker JC
J Invest Dermatol; 2009 Feb; 129(2):406-14. PubMed ID: 18650848
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy: facts to clear the alleged clouds.
Morton DL; Elashoff R
Arch Dermatol; 2008 May; 144(5):685-6; author reply 687. PubMed ID: 18490604
[No Abstract] [Full Text] [Related]
13. Role of apaf-1 in melanoma drug resistance and apoptosis.
Röckmann H; Schadendorf D
J Invest Dermatol; 2005 Aug; 125(2):386-7. PubMed ID: 16098052
[No Abstract] [Full Text] [Related]
14. Prognostic factors in melanoma outcome and survival.
Le TT; Pitman KT
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):33-41. PubMed ID: 15062285
[No Abstract] [Full Text] [Related]
15. Anomalous lymphatic drainage patterns in patients with cutaneous melanoma.
Thompson JF; Uren RF
Tumori; 2001; 87(4):S54-6. PubMed ID: 11693824
[No Abstract] [Full Text] [Related]
16. Function association of tissue inhibitor of metalloproteinase-1 and malignant melanoma: systomics approach.
Wiwanitkit V
Acta Dermatovenerol Croat; 2010; 18(1):68. PubMed ID: 20361890
[No Abstract] [Full Text] [Related]
17. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein.
Botelho MG; Wang X; Arndt-Jovin DJ; Becker D; Jovin TM
J Invest Dermatol; 2010 May; 130(5):1400-10. PubMed ID: 19759550
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc E; Strömblad S; von Schalscha TL; Mitjans F; Piulats J; Montgomery AM; Cheresh DA; Brooks PC
Cancer Res; 1999 Jun; 59(11):2724-30. PubMed ID: 10363998
[TBL] [Abstract][Full Text] [Related]
19. Nutrition and melanoma.
Wagner RF; DiSorbo DM; Nathanson L
Int J Dermatol; 1984 Sep; 23(7):453-7. PubMed ID: 6386713
[No Abstract] [Full Text] [Related]
20. Lymph node removal may provide prognostic information for melanoma patients.
Oncology (Williston Park); 1996 Nov; 10(11):1637-8. PubMed ID: 8953584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
